Enhanced secretion of insulin plays a role in the development of atherosclerosis and restenosis of coronary arteries: Elective percutaneous transluminal coronary angioplasty in patients with effort angina

Journal of the American College of Cardiology

Volumn 32, Issue 6, 1998, Pages 1624-1629

  Nishimoto, Yasuhiro ^a   Miyazaki, Yutaka ^b   Toki, Yukio ^b   Murakami, Ryuichiro ^a   Shinoda, Masanori ^a   Fukushima, Akihiko ^a   Kanayama, Hitoshi ^a,c  

^a Kamo Hospital   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Kamo Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; ELECTIVE SURGERY; FEMALE; HUMAN; INSULIN RELEASE; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARTERIOSCLEROSIS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; EXERTION; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MIDDLE AGED; RECURRENCE; REGRESSION ANALYSIS;

EID: 0032533938     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00428-8     Document Type: Article

References (32)

1. Stout RW. Insulin and atheroma 20-yr perspective. Diabetes Care 1990;13: 631-54.
2. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37: 1595-607.
3. Yamagishi M, Miyatake K, Tamai J, Nakatani S, Koyama J, Nissen SE. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol 1994;23:352-7.
4. Shinozaki K, Suzuki M, Ikebuchi M, et al. Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation 1995;92:1749-57.
5. Suzuki M, Nishizaki M, Arita M, Kakuta T, Numano F. Impaired glucose tolerance with late hypersecretion of insulin during oral glucose tolerance test in patients with vasospastic angina. J Am Coll Cardiol 1996;27:1458-63.
6. Creager MA, Liang C-S, Coffman JD. Beta adrenergic-mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther 1985;235: 709-14.
7. Yagi S, Takata S, Kiyokawa H, et al. Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein. Diabetes 1988;37:1064-7.
8. 2 and synthesis of prostacyclin by insulin in unstable angina pectoris and in acute myocardial infarction. Am J Cardiol 1992;70:582-6.
9. Ghazzi MN, Perez JE, Antonucci TK, et al. Cardiac and glycemic benefits of troglitazone treatment in NIDDM. Diabetes 1997;46:433-9.
10. Bogaty P, Brecker SJ, White SE, et al. Comparison of coronary angiographic findings in acute and chronic first presentation of ischemic heart disease. Circulation 1993;87:1938-46.
11. Ryan TJ, Bauman WB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American Heart Association/American College of Cardiology task force on assessment of diagnostic and therapeutic cardiovascular procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1993;88:2987-3007.
12. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA 1979;241:2035-8.
13. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation 1990; 82:27-36.
14. Spallarossa P, Cordera R, Andraghetti G, Bertero G, Brunelli C, Caponnetto S. Association between plasma insulin and angiographically documented significant coronary artery disease. Am J Cardiol 1994;74:177-9.
15. Després JP, Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334: 952-7.
16. Shinozaki K, Hara Y, Suzuki M, Harano Y, Ikebuchi M. Demonstration of insulin resistance in coronary artery disease documented with angiography. Diabetes Care 1996;19:1-7.
17. Hamsten A, Eféndic S, Walldius G, Szamosi A, Faire U. Glucose tolerance and insulin response to glucose in nondiabetic young male survivors of myocardial infarction. Am Heart J 1987;113:917-27.
18. DeFronzo RA. Lilly lecture 1987. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-87.
19. Stein B, Weintraub WS, Gebhart SSP, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-89.
20. Bourassa MG, Lespérance J, Eastwood C, et al. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1991;18:368-76.
21. Peters RJG, Kok WEM, Mario CD, et al. Prediction of restenosis after coronary balloon angioplasty: results of PICTURE (post-intracoronary treatment ultrasound result evaluation), a prospective multicenter intracoronary ultrasound imaging study. Circulation 1997;95:2254-61.
22. Waller BF, Pinkerton CA, Orr CM, Slack JD, VanTassel JW, Peters T. Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: a necropsy study of 20 patients. J Am Coll Cardiol 1991;17:58B-70B.
23. Steele PM, Chesebro JH, Stanson AW, et al. Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model. Circ Res 1985;57:105-12.
24. Schwartz RS, Holmes DR Jr, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992;20: 1284-93.
25. Baykal D, Schmedtje JF, Runge MS. Role of the thrombin receptor in restenosis and atherosclerosis. Am J Cardiol 1995;75:82B-7B.
26. Epstein SE, Speir E, Unger EF, Guzman RJ, Finkel T. The basis of molecular strategies for treating coronary restenosis after angioplasty. J Am Coll Cardiol 1994;23:1278-88.
27. Cercek B, Sharifi B, Barath P, Bailey L, Forrester JS. Growth factors in pathogenesis of coronary arterial restenosis. Am J Cardiol 1991;68:24C-33C.
28. Nakao J, Ito H, Kanayasu T, Murota S. Stimulatory effect of insulin on aortic smooth muscle cell migration induced by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid and its modulation by elevated extracellular glucose levels. Diabetes 1985;34:185-91.
29. Cascieri MA, Chicchi GG, Hayes NS, Slater EE. Stimulation of DNA synthesis in rat A10 vascular smooth muscle cells by threonine-59 insulin-like growth factor I. Circ Res 1986;59:171-7.
30. Schneider DJ, Nordt TK, Sobel BE. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes 1993;42:1-7.
31. Kornowski R, Mintz GS, Kent KM, et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. Circulation 1997;95:1366-9.
32. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med 1976;295:420-5.